explore -WSS

explore

author：fashion 2025-08-11 07:59:03 - browse：6

Photo illustration of the FDA US Food and Drug website. -- health policy coverage from STAT — Adobe

WASHINGTON — Food and Drug Administration officials hope to finish this year a massive overhaul of the way the agency inspects facilities that make drugs, medical devices, and food products, they said Friday.

The reorganization was spurred by the FDA’s mishandling of the infant formula crisis. The agency was slow to inspect a major infant formula plant despite a whistleblower complaint about deadly bacterial contamination at the facility. An investigation found that the delayed response was due in part to the agency’s organization. A nonprofit, nonpartisan advisory body reported in December it was not clear who is in charge of food oversight, and agency food safety staff are siloed among divisions that don’t communicate with each other.

Although the food center has been the focus of attention in the reorganization, it will affect a huge swath of the agency. The reorganization is expected to impact about 8,000 FDA employees, according to Michael Rogers, FDA associate commissioner for regulatory affairs. The Office of Regulatory Affairs, which will be called the Office of Inspections and Investigations under the proposed reorganization, will go from having about 5,100 full-time employees to 3,586 employees.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： Walensky prepares to leave CDC — and Congress — behind
Next article： Regeneron agrees to White House price limits on anti

WSS

How housing is health care on Long Island

CVS is willing to dump 10% of its Medicare Advantage members

STAT reporters are Pulitzer Prize finalists for investigative reporting

WATCH: Why do bright lights make us see spots?

STAT series 'Denied by AI' wins major journalism prizes

Hospitals consider fixing cancer drug shortages on their own

knowledge

explore

entertainment

State Dept. review finds Biden bears some blame for Afghanistan failures

Hottest summer in 2,000 years puts focus on extreme heat, health

Medicare details structure of new drug price negotiation program

FDA approves updated Covid vaccines

Bright Health sells Medicare Advantage business to Molina

WuXi Biologics beefs up its lobbying operation

Medicare proposal to cover medical devices draws a mixed reaction

HHS suspends federal funding for EcoHealth Alliance

23andMe had bad news about my health. I wish a person had delivered it

Fertility clinic egg and embryo storage is a disaster

entertainment

Acelyrin, a rare IPO success, stumbles in its first big test

Acelyrin, a rare IPO success, stumbles in its first big test

Pig kidney works a record two months in donated body

Novo Nordisk testing Wegovy against alcohol

Free medical tuition alone isn't enough to close gaps in primary care

FDA panel endorses Alnylam’s heart drug — after picking it apart

focus

Wikipedia

entertainment

hotspot